Effects of Shexiang Baoxin Pill for Coronary Microvascular Function: A Systematic Review and Meta-Analysis

Abstract

Background: The coronary microvascular dysfunction has attracted more and more attention in recent years, but there is still a lack of effective treatment. Shexiang Baoxin Pill is one of the commonly used drugs for the treatment of coronary artery disease in China. More recently, some studies found that it has the effect of improving coronary microvascular function.Objective: To evaluate the effects of Shexiang Baoxin Pill for coronary microvascular function.Methods: Databases including MEDLINE, Web of Science, CNKI, Wanfang, The Cochrane Library, EMbase, VIP and CBM were searched from inception to June 2021 to screen out relevant clinical studies. The 2019 version 2 of the Cochrane risk of bias tool (RoB2) were used to assess the methodological quality of the included studies. RevMan 5.3 software was used for meta-analysis.Results: Eleven studies meeting the criteria were included, with a total of 1,075 patients. The results of meta-analysis showed that compared with conventional treatment alone, combination of Shexiang Baoxin Pill and conventional treatment can further increase the coronary flow reserve (CFR) [mean difference (MD) = 0.43, 95%CI (0.28, 0.58), p < 0.000 01], decrease the index of microvascular resistance (IMR) [MD = −4.23, 95%CI (−5.49, −2.97), p < 0.000 01], increase serum nitric oxide (NO) [MD = 11.96, 95%CI (2.74, 21.18), p = 0.001] and decrease serum hypersensitive C-reactive protein (hs-CRP) [MD = −2.49, 95%CI (−3.08, −1.90), p < 0.000 01], but did not increase the time of duration on the exercise testing (TET) [MD = 3.64, 95%CI (−1.17, 8.45), p = 0.14]. In terms of safety, a total of 10 patients developed adverse reactions in the intervention group and 17 patients developed adverse reactions in the control group.Conclusion: Current evidence suggests that Shexiang Baoxin Pill may be effective in the improvement of coronary microvascular function when used in combination with conventional treatment. However, due to the low quality of the included studies, lack of placebo control and high heterogeneity among different studies, we should take a cautious attitude towards this conclusion. Moreover, the safety of Shexiang Baoxin Pill remains uncertain, more high-quality clinical studies are needed to verify the efficacy and safety of this drug in the future.Systematic Review Registration: [website], identifier [registration number: CRD42021265113].

Protective effects of muscone on traumatic spinal cord injury in rats

“…It has pharmacological effects, including promoting blood circulation and menstruation, inducing resuscitation, and exerting anti-inflammatory activity (21)(22)(23)(24)(25)(26). It is widely used in the treatment of dementia, cerebral ischemia, myocardial infarction, diabetic peripheral neuropathy, vertebral endplate degeneration, injury, inflammation, cancer, and other diseases (27)(28)(29)(30)(31)(32)(33)(34)(35)(36)(37)(38). Muscone is one of the anti-inflammatory constituents in a well-known traditional Chinese medicine named Pian-Tze Huang (39).…”

Chuanzhitongluo capsule ameliorates microcirculatory dysfunction in rats: Efficacy evaluation and metabolic profiles

“…However, available therapeutic options (ie, thrombolysis and surgical thrombectomy) were very limited so far (Miranda et al, 2016). Extensive clinical evidences supported that blood-activating and stasis-removing drugs provided excellent efficacy in improving microvascular function and clinical prognosis (Fang et al, 2022;Wang et al, 2021; M. X. Zhang et al, 2022).…”

Meta-analysis and trial sequential analysis of shexiang baoxin pill for coronary slow flow

“…From an anatomical point of view, since epicardial arteries are normal in patients with CSF and they do not pose any resistance to blood flow (conductive vessels), the cause of slow blood flow is mainly related to the “small vessels” (resistance vessels) of <400 μm, which are the most important parts regulating myocardial blood flow ( Wang and Nie, 2011 ). Wang et al found that SXBXP significantly increased coronary flow reserve and decreased microcirculatory resistance, and these indicators directly reflected the function of coronary microcirculation, which is closely related to coronary blood flow velocity ( Wang et al, 2021 ). Basic studies have revealed that the active components of SXBXP, such as cinnamaldehyde and ginsenosides, produce pro-angiogenic effects by stimulating VEGF, PI3K/Akt/mTOR, and MAPK pathways, which are responsible for promoting angiogenesis, enhancing endothelial cell proliferation, mobilization, and tube formation, and increasing the number and density of microvessels ( Lu et al, 2018 ; Hua et al, 2021 ).…”